Accelerate Flu Detection Kit Development with OEM by QIAGEN Pathogen Workflow

The Emergence of Influenza

Influenza, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from 1–4 days after exposure to the virus and last for about 2–8 days.

Influenza research is wide-ranging and includes efforts to understand how influenza viruses enter hosts, the relationship between influenza viruses and bacteria, how influenza symptoms progress, and what make some influenza viruses deadlier than others. Non-structural proteins encoded by influenza viruses are periodically discovered and their functions are continually under research[1].

*Total cases reported at FluNet in Western Pacific Region, from week 1 to week 52, 2022[2]

In a typical year, 5–15% of the population contracts influenza. There are 3–5 million severe cases annually, with up to 650,000 respiratory-related deaths globally each year. Deaths most commonly occur in high-risk groups, including young children, the elderly, and people with chronic health conditions. In temperate regions of the world, the number of influenza cases peaks during winter, whereas in the tropics influenza can occur year-round.

The Importance of Innovation in Pathogen Detection

Microorganisms are found everywhere and are more active during the winter season where the climate are colder. These harmful microorganisms are known as pathogen, and is considered as the major vectors/carriers for various communicable diseases. In OEM by QIAGEN, we help our partners to develop and customize unique solutions through microbe testing, pathogen screening, and environmental monitoring systems. We achieve this by providing our partners access to QIAGEN’s sample preparation and detection technology to unravel various pathogen and characterizing pathogen of interest.

In general, pathogens have diverse compositions, interactions and functions. PCR technology can identify these pathogen which are harmful for our health and our surrounding environment. The forefront of pathogen detection focuses on how these microorganisms negatively affect us by analyzing pathogen targets, monitor antibiotic resistance or identify the presence of virulence genes. As our OEM partners, your company will need reliable and advanced innovations for microbiome detection, identification and quantification.

Emphasizing the importance of pathogen detection, we at OEM by QIAGEN partnered with innovators like yourself to develop dedicated products and workflows to prepare for future pathogen outbreaks. Our global project managers help to simplify the complexities in OEM development in various DNA sample processing. Our technologies and expert teams will support you in every step of product development process and optimize the products for your desired sample types.

In OEM by QIAGEN, we help OEM partners develop and customize unique solutions for pathogen detection processes. We achieve this by providing our partners access to QIAGEN’s PCR technology, tailored to your commercial and healthcare needs. By offering extensive product portfolio in our pathogen workflow, our state-of-the art research and development departments are committed to develop new tools to address the changing needs of our diverse customers.

OEM by QIAGEN Pathogen Workflow – A simplified guide for our partners in accelerating innovation

Our pathogen detection is mainly focused on PCR and RT-PCR workflow, ensuring accurate replication of pathogenic DNA sequences. This reliability contributes to a streamlined workflow by reducing the need for repeated experiments and troubleshooting. As our partner, you can save valuable time and resources, allowing you to focus on the core objectives and enhance overall productivity. By incorporating our custom solutions into the experimental processes, your scientists can accelerate their innovation and drive results with confidence.

At OEM by QIAGEN, we offer a range of products and services, each designed to meet various research requirements. These can include sample preparations and PCR analyses catered for your needs, enabling scientists to customize their experiments and achieve precise outcomes. The variety of products offered in OEM expands the horizons of research possibilities, allowing scientists to explore novel applications and push the boundaries of their scientific endeavors. It is our commitment to provide tailored solutions through our portfolio, which empowers you to unlock new insights and catalyze innovation.

OEM by QIAGEN accelerates your innovation by accelerating manufacturing of quality enzymes and master mixes for your genomic assays

Our products are our commitments to identify, develop, and deliver the best enzyme technologies for you. If your company has a requirement for a product sourcing and a manufacturing partner that stands above the crowd then let’s connect via LinkedIn connections or leave a message via email ([email protected]).

Author:

Jeff Ng Jun Bin, Marketing Communication Associate APAC.

References:

[1] Hao W, Wang L, Li S. Roles of the Non-Structural Proteins of Influenza A Virus. Pathogens. 9(10): 812. doi:10.3390/pathogens9100812. PMC 7600879. PMID 33023047.

[2] World Health Organization FluNet Bi-weekly Influenza Situation Update. https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/influenza-surveillance-outputs

Detect Pathogens with Customized Workflow

Accelerate Your Innovation with OEM by QIAGEN!

Follow us on LinkedIn: OEM by QIAGEN